Ordering
Available Variants5 g
CHA.24022-5g
Price
€44.32
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHA.24022-5g | €44.32 |
95%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H26N2O2 |
|---|---|
| CAS Number | 1435-55-8 |
| Molecular Weight | 326.43 |
| UNSPSC Code | 12352005 |
| NACRES | NA.22 |
| PubChem Substance ID | 24862070 |
| EC Number | 215-862-5 |
| Beilstein/REAXYS Number | 91441 |
| MDL number | MFCD00135599 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| pcodes | P264 - P270 - P301 + P312 - P501 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
Hydroquinidine, with a Chemical Abstracts Service (CAS) registry number of 1435-55-8, is a medicinal compound that belongs to the class of quinidine derivatives. It is primarily utilized as an antiarrhythmic agent, which functions by regulating abnormal heart rhythms. The chemical structure of hydroquinidine consists of a quinoline ring system, and its pharmacological properties are attributed to its ability to block sodium and potassium channels in the heart. As a result, hydroquinidine is effective in treating various types of arrhythmias, including atrial fibrillation and ventricular tachycardia. Its therapeutic applications are well-established, and it is often administered orally or intravenously, depending on the specific clinical scenario. The compounds efficacy and safety profile have been extensively studied, and it remains a valuable option in the management of cardiac arrhythmias.
